SickKids scientists lay the groundwork for early detection of cardiomyopathy

In the first study to use whole genome sequencing to examine tandem repeat expansions in heart conditions, scientists at The Hospital for Sick Children (SickKids) have laid the groundwork for early detection of and future precision therapies for cardiomyopathy.

Reunion Neuroscience Inc. to Participate in October Investor Conferences – Psychedelic Alpha

WILMINGTON, N.C., Oct. 05, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions

November 1, 2023

AstraZeneca’s SERD hits primary endpoint in late-stage trial, but first-line potential remains uncertain

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 27, 2025

Can Childhood Trauma Prime Brain Dynamics for Nicotine Dependence?

Childhood trauma-related emotion dysregulation may partly explain why some long-term smokers are unable to give up nicotine, a cross-sectional study suggested. Using 16-minute resting-state functional

January 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.